We are delighted that Sowmya Kaur, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences together with Dr. Atul Gupta, Associate Vice President Medical Monitoring, Navitas Life Sciences have had their article, Innovative Trial Designs, published in issue 43 of Pharma Focus Asia.
The median investment to bring a new drug to market is estimated at $985 million, which is expected to rise further in the current COVID-19 era. To improve efficiency of clinical trials, lower costs and enhance data quality while ensuring patient access to new treatments, the drug development industry is pursuing new seamless approaches to clinical trial design. The innovative approach to contemporary clinical trial designs like integrated trials, basket trials, therapeutic repurposing during the trial etc. will not only optimize the cost and speed but will inspire both investigators and pharmaceutical companies for cutting-edge scientific discoveries.
Please complete the form to download a copy of the article.
Published in Pharma Focus Asia | Issue 43 | June, 2021 | Pages 56 - 61